Gadolinium Enhanced Dual-Energy Computed Tomography: A Feasibility Study to Assess Image Quality and Diagnostic Confidence
Status: Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 10 Dec 2018
Price : $35 *
At a glance
- Drugs Gadofosveset (Primary)
- Indications Diagnostic-imaging-abnormalities
- Focus Diagnostic use
- 27 Sep 2016 Planned initiation date changed from 1 Mar 2015 to 1 Dec 2016.
- 28 Jan 2015 Planned initiation date changed from 1 Aug 2014 to 1 Mar 2015 as reported by ClinicalTrials.gov.
- 24 Jul 2014 New trial record